KDOQI (Kidney Disease Outcomes Quality Initiative)

NKF KDOQI GUIDELINES

Executive Summaries of 2000 Updates | Anemia | Hemodialysis | Peritoneal Dialysis
Vascular Access | Nutrition | Chronic Kidney Disease | History of DOQI

 

KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification

Figures

Figure 1   Evidence Model for Stages in the Initiation and Progression of Chronic Kidney Disease and Therapeutic Interventions
Figure 2 Incidence and Prevalence of End-Stage Renal Disease in the US
Figure 3 Evidence Model for Stages in the Initiation and Progression of Cardiovascular Disease and Therapeutic Interventions
Figure 4 Kidney Function Decline in Chronic Kidney Disease
Figure 5 Creatinine Distribution: US Population Age 20 by Sex
Figure 6 Cardiovascular Mortality in the General Population (NCHS) and in ESRD Treated by Dialysis (USRDS)
Figure 7 Prevalence of Albuminuria and High Blood Pressure (%) in US Adults Age 20 Years, NHANES III, 1988-1994
Figure 8 Distribution of Albumin-to-Creatinine Ratio in US Men and Women, Age 20 Years: NHANES III, 1988-1994
Figure 9 GFR vs. Age
Figure 10 Percentiles of GFR Regressed on Age (NHANES III)
Figure 11  Level of GFR at Initiation of Replacement Therapy (USRDS)
Figure 12 Relationship of Creatinine Clearance and Serum Creatinine With GFR (Inulin Clearance) in Patients With Glomerular Disease
Figure 13 Estimates of GFR vs. Measured GFR Among MDRD Study Baseline Cohort
Figure 14 Accuracy of Different Estimates of GFR in AduPrevalence of Patients by Number of Abnormalities by Level of GFR (NHANES III)
Figure 15 Prevalence of Patients by Number of Abnormalities by Level of GFR (NHANES III)
Figure 16 Proportion of Patients by Number of Abnormalities by Level of GFR (NHANES III)
Figure 17 Relationship Between Blood Pressure and Progression of Diabetic Kidney Disease
Figure 18 Relationship Between Mean Arterial Blood Pressure and GFR Decline
Figure 19 Relationship Between Systolic Blood Pressure and Graft Survival
Figure 20 Mortality vs. Systolic Blood Pressure in Hemodialysis Patients
Figure 21 Prevalence of High Blood Pressure by Level of GFR in the MDRD Study
Figure 22  Prevalence of High Blood Pressure by Level of GFR, Adjusted to Age 60 Years (NHANES III)
Figure 23 Prevalence of Elevated Serum Creatinine by JNC–VI Blood Pressure Category and Self-Reported Treatment With Anti-Hypertensive Medications (NHANES III)
Figure 24 Estimated Number of Individuals With Elevated Serum Creatinine by JNC–VI Blood Pressure Category and Self-Reported Treatment With Anti-Hypertensive Medications (NHANES III)
Figure 25 Anemia Work-Up for Patients With Chronic Kidney Disease
Figure 26 Blood Hemoglobin Percentiles by GFR Adjusted to Age 60 (NHANES III)
Figure 27 Adjusted Prevalence in Adults of Low Hemoglobin by GFR (NHANES III)
Figure 28 Hemoglobin Percentiles by GFR
Figure 29 Prevalence of Low Hemoglobin by GFR Category
Figure 30 Association of Dietary Intake and GFR
Figure 31 Serum Albumin Percentiles by GFR Adjusted to Age
Figure 32 Association of Serum Albumin and GFR
Figure 33 Association of Serum Transferrin and GFR
Figure 34 Association of Serum Cholesterol and GFR
Figure 35 Association of Body Composition and GFR
Figure 36 Scatterplot of iPTH vs. GFR
Figure 37 iPTH Percentiles by GFR
Figure 38 Prevalence of High iPTH by GFR Category
Figure 39 Serum Calcium Levels (Adjusted for Albumin) vs. GFR
Figure 40 Prevalence of Hypocalcemia (Adjusted for Albumin) vs. GFR
Figure 41 Serum Phosphorus Levels vs. GFR (NHANES III)
Figure 42 Prevalence of Low Calcium and High Phosphate by GFR Category
Figure 43 Calcium-Phosphorus Product Percentiles by GFR (NHANES III)
Figure 44 Kidney Function (GFR) and Odds of Having Symptoms Affecting Quality of Life and Well-Being
Figure 45 Adjusted Prevalence of Physical Inability to Walk by GFR Category (NHANES III)
Figure 46 Adjusted Prevalence of Physical Inability to Lift by GFR Category (NHANES III)
Figure 47 GFR Slopes in the Modification of Diet in Renal Disease Study
Figure 48 Composite Plot of Reciprocal Serum Creatinine vs. Time in Six Patients With Chronic Kidney Disease
Figure 49 Plot of Reciprocal of Plasma Creatinine (1/PCr) in a Patient
Figure 50 Comparison of GFR Decline Between Diet Groups in the Modification of Diet in Renal Disease Study
Figure 51 Cardiovascular Mortality With Diabetes
Figure 52 Microalbuminuria and Cardiovascular Morbidity With Type 2 Diabetes
Figure 53 GFR and Relative Risk for Death
Figure 54 Proteinuria and Relative Risk for Cardiovascular Disease
Figure 55 Proteinuria and Relative Risk for CVD Death
Figure 56 Proteinuria and Relative Risk for Death
Figure 57 Evaluation of Proteinuria in Patients Not Known to Have Kidney Disease

2002 National Kidney Foundation, Inc